Phibro Animal Health | PAHC - Ebitda


Phibro Animal Health reported $68.1M in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
Align Technology USD 183.84M 19.77M Sep/2025
ANI Pharmaceuticals USD 65.36M 5.76M Dec/2025
Aurora Cannabis CAD 18.48M 3.11M Dec/2025
Bristol-Myers Squibb USD 4.24B 967M Sep/2025
Canopy Growth CAD -2.87M 19.49M Dec/2025
Corcept Therapeutics USD 4.2M 6.5M Dec/2025
Eli Lilly USD 7.88B 378.1M Sep/2025
Henry Schein USD 291M 4M Dec/2025
Idexx Laboratories USD 391.47M 17.97M Sep/2025
Knight Therapeutics CAD 24.45M 3.46M Dec/2025
Merck USD 8.39B 1.97B Sep/2025
Nektar Therapeutics USD -31.81M 70K Sep/2023
Pacira USD 38.71M 10.65M Dec/2025
Phibro Animal Health USD 68.1M 6.2M Dec/2025
Prestige Brands USD 90.82M 3.99M Dec/2025
Supernus Pharmaceuticals USD 48.5M 6.6M Dec/2025
Zoetis USD 1.04B 87M Sep/2025